Why Bellamy's Australia Ltd shares stormed to a record high today

The Bellamy's Australia Ltd (ASX:BAL) share price is at a record high and up 500% since this time last year…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performers on the local share market on Monday has been the Bellamy's Australia Ltd (ASX: BAL) share price.

At the time of writing the infant formula company's shares are up 7% to an all-time high of $22.66.

Incredibly, this means that Bellamy's shares have now risen a staggering 500% over the last 12 months after it staged a miraculous recovery.

Why are its shares higher today?

With no news out of the company, I suspect that today's gain can be attributed to Bellamy's shares being included in the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) today following the March rebalance.

Being included on the S&P/ASX 200 means that index funds like BlackRock's ISHAUS200/ETF (ASX: IOZ) will need to pick up shares in order to track the benchmark index accurately.

Furthermore, some fund managers have restrictions on the shares that they can buy. One common restriction is shares outside the benchmark index. Bellamy's inclusion means these fund managers can now add it to their portfolios.

The shares of fellow additions to the index Xero Limited (ASX: XRO), Smartgroup Corporation Ltd (ASX: SIQ), and Ausdrill Limited (ASX: ASL) are all pushing higher today, albeit not as strongly as Bellamy's.

Should you invest?

While I think that Bellamy's has a bright future ahead of it and could deliver a result in both FY 2018 and FY 2019 that more than justifies the premium its shares trade at, I would still prefer to buy in at a lower price.

Further, although I think it is a similar story for A2 Milk Company Ltd (ASX: A2M), I would pick a2 Milk Company ahead of Bellamy's due to the fact it already has its Chinese accreditation in place and is rapidly winning market share. I think this makes it less risky than Bellamy's at this stage.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »